bearish

Fu Shou Yuan

Fu Shou Yuan (1448.HK) - Investment Strategy May Need to Be Adjusted

742 Views22 Jan 2025 00:55
​Fu Shou Yuan's 2024 performance may disappoint due to growth challenges beyond Shanghai, caution advised on holding stock long-term, buy at low price and consider profit-taking at higher valuation.
What is covered in the Full Insight:
  • Introduction
  • Current Challenges
  • Strategic Adjustments
  • Future Risks and Opportunities
  • Conclusion
Boomeranged on Mon, 27 Jan 2025 03:50
The special dividend this time exceeded expectations, thus driving up the share price.However, since Fu Shou Yuan’s future revenue growth rate would inevitably fall to single digit as the management has decided to slow down the pace of acquisition, high valuation is unsustainable.So, for investors who earn capital gains rather than dividends, we recommend taking profits while the stock price rises
SUMMARY
(Sign Up to Access)
Begin exploring Smartkarma's AI-augmented investing intelligence platform with a complimentary Preview Pass to:
  • Unlock research summaries
  • Follow top, independent analysts
  • Receive personalised alerts
  • Access Analytics, Events and more

Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.

Upgrade later to our paid plans for full-access.

or
Already have an account? Sign In Now
Full Insight
(Paid Plans Only, 3-minute read)
Related Insights
More »
    Loading
Trending Collections
More »
    Loading
Trending Insights
More »
    Loading
Top Unpaywalled Insights
More »
    Loading
Discussions
(Paid Plans Only)
chart-bar
Logo
Top 5%
Xinyao (Criss) Wang
HK/China Healthcare Analyst (ex-Fosun Pharma)
ChinaHealth CareEquity Bottom-UpThematic (Sector/Industry)
Price Chart(Sign Up to Access)
analytics-chart
x